- Home
- BRTX vs AQMS Comparison
BRTX vs AQMS Comparison
Compare BRTX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- AQMS
- Stock Information
- Founded
- BRTX 1997
- AQMS 2014
- Country
- BRTX United States
- AQMS United States
- Employees
- BRTX N/A
- AQMS N/A
- Industry
- BRTX Managed Health Care
- AQMS Metal Fabrications
- Sector
- BRTX Health Care
- AQMS Industrials
- Exchange
- BRTX Nasdaq
- AQMS Nasdaq
- Market Cap
- BRTX 10.7M
- AQMS 13.7M
- IPO Year
- BRTX N/A
- AQMS 2015
- Fundamental
- Price
- BRTX $1.58
- AQMS $1.79
- Analyst Decision
- BRTX Strong Buy
- AQMS Strong Buy
- Analyst Count
- BRTX 1
- AQMS 2
- Target Price
- BRTX $18.00
- AQMS $30.00
- AVG Volume (30 Days)
- BRTX 1.1M
- AQMS 87.5K
- Earning Date
- BRTX 03-28-2025
- AQMS 03-26-2025
- Dividend Yield
- BRTX N/A
- AQMS N/A
- EPS Growth
- BRTX N/A
- AQMS N/A
- EPS
- BRTX N/A
- AQMS N/A
- Revenue
- BRTX $377,000.00
- AQMS N/A
- Revenue This Year
- BRTX $482.76
- AQMS N/A
- Revenue Next Year
- BRTX $212.24
- AQMS N/A
- P/E Ratio
- BRTX N/A
- AQMS N/A
- Revenue Growth
- BRTX 189.55
- AQMS 525.00
- 52 Week Low
- BRTX $1.03
- AQMS $1.33
- 52 Week High
- BRTX $2.55
- AQMS $14.14
- Technical
- Relative Strength Index (RSI)
- BRTX 41.43
- AQMS 42.13
- Support Level
- BRTX $1.46
- AQMS $1.65
- Resistance Level
- BRTX $1.68
- AQMS $1.98
- Average True Range (ATR)
- BRTX 0.22
- AQMS 0.22
- MACD
- BRTX -0.01
- AQMS -0.03
- Stochastic Oscillator
- BRTX 25.81
- AQMS 14.63
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.